Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Rippe, Catarina ^a   Zhu, Baoyi ^a   Krawczyk, Katarzyna K ^a   Bavel, Ed Van ^b   Albinsson, Sebastian ^a   Sjölund, Jonas ^c   Bakker, Erik N T P ^b   Swärd, Karl ^a  

^a LUND UNIVERSITY   (Sweden)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; GUANYLATE CYCLASE; GUCY1A3 PROTEIN, MOUSE; GUCY1B3 PROTEIN, MOUSE; MESSENGER RNA; NOTCH RECEPTOR;

ANIMAL; AORTA; C57BL MOUSE; CHEMICALLY INDUCED; GENE EXPRESSION; GENETICS; HUMAN; HYPERTENSION; METABOLISM; SIGNAL TRANSDUCTION; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; AORTA; GENE EXPRESSION; HUMANS; HYPERTENSION; MICE, INBRED C57BL; RATS, INBRED WKY; RECEPTORS, NOTCH; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOLUBLE GUANYLYL CYCLASE;

EID: 85018280054     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-01392-1     Document Type: Article

References (47)

1. Kita, T. LOX-1, a possible clue to the missing link between hypertension and atherogenesis. Circ Res 84, 1113-1115, doi: 10.1161/01.RES.84.9.1113 (1999).
2. Ishibashi, M. et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24, e174-178, doi: 10.1161/01.ATV.0000143384.69170.2d (2004).
3. Panza, J. A., Quyyumi, A. A., Brush, J. E. Jr. & Epstein, S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323, 22-27, doi: 10.1056/NEJM199007053230105 (1990).
4. Bian, K. & Murad, F. Nitric oxide (NO)-biogeneration, regulation, and relevance to human diseases. Front Biosci 8, d264-278, doi: 10.2741/997 (2003).
5. Schiffrin, E. L., Park, J. B., Intengan, H. D. & Touyz, R. M. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101, 1653-1659, doi: 10.1161/01.CIR.101.14.1653 (2000).
6. Bauersachs, J. et al. Vasodilator dysfunction in aged spontaneously hypertensive rats: Changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc Res 37, 772-779, doi: 10.1016/S0008-6363(97)00250-2 (1998).
7. Ruetten, H., Zabel, U., Linz, W. & Schmidt, H. H. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 85, 534-541, doi: 10.1161/01.RES.85.6.534 (1999).
8. Lucas, K. A. et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52, 375-414 (2000).
9. International Consortium for Blood Pressure Genome-Wide Association, S. et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478., 103-109, doi 10.1038/nature10405 (2011).
10. Lu, X. et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet 44, 890-894, doi: 10.1038/ng.2337 (2012).
11. Erdmann, J. et al. Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature 504, 432-436, doi: 10.1038/nature12722 (2013).
12. Herve, D. et al. Loss of alpha1beta1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. Am J Hum Genet 94, 385-394, doi: 10.1016/j.ajhg.2014.01.018 (2014).
13. Chang, A. C. et al. Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Dev Cell 21, 288-300, doi: 10.1016/j.devcel.2011.06.022 (2011).
14. Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 137, 216-233, doi: 10.1016/j.cell.2009.03.045 (2009).
15. Yatim, A. et al. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell 48, 445-458, doi: 10.1016/j.molcel.2012.08.022 (2012).
16. Hoglund, V. J. & Majesky, M. W. Patterning the artery wall by lateral induction of Notch signaling. Circulation 125, 212-215, doi: 10.1161/CIRCULATIONAHA.111.075937 (2012).
17. Fouillade, C. et al. Transcriptome analysis for Notch3 target genes identifies Grip2 as a novel regulator of myogenic response in the cerebrovasculature. Arterioscler Thromb Vasc Biol 33, 76-86, doi: 10.1161/ATVBAHA.112.251736 (2013).
18. Hayette, S. et al. AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner. Cancer Res 65, 6521-6525, doi: 10.1158/0008-5472.CAN-05-1325 (2005).
19. Briot, A. et al. Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells. Dev Cell 31, 707-721, doi: 10.1016/j.devcel.2014.11.023 (2014).
20. Henshall, T. L. et al. Notch3 is necessary for blood vessel integrity in the central nervous system. Arterioscler Thromb Vasc Biol 35, 409-420, doi: 10.1161/ATVBAHA.114.304849 (2015).
21. Chen, Z. et al. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene 33, 3869-3877, doi: 10.1038/onc.2013.348 (2014).
22. Kitagawa, M. Notch signalling in the nucleus: Roles of Mastermind-like (MAML) transcriptional coactivators. J Biochem 159, 287-294, doi: 10.1093/jb/mvv123 (2016).
23. El-Sehemy, A. et al. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells. Cell Signal 25, 2780-2787, doi: 10.1016/j.cellsig.2013.09.008 (2013).
24. Konishi, M. & Su, C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 5, 881-886, doi: 10.1161/01.HYP.5.6.881 (1983).
25. Lockette, W., Otsuka, Y. & Carretero, O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 8, II61-66, doi: 10.1161/01.HYP.8.6-Pt-2.II61 (1986).
26. Perticone, F. et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104, 191-196, doi: 10.1161/01.CIR.104.2.191 (2001).
27. Rajagopalan, S. et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97, 1916-1923, doi: 10.1172/JCI118623 (1996).
28. Kloss, S., Bouloumie, A. & Mulsch, A. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 35, 43-47, doi: 10.1161/01.HYP.35.1.43 (2000).
29. Jacke, K., Witte, K., Huser, L., Behrends, S. & Lemmer, B. Contribution of the renin-angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2)27 rats. Eur J Pharmacol 403, 27-35, doi: 10.1016/S0014-2999(00)00577-X (2000).
30. Lopez-Farre, A. et al. Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: Effect of the alpha1-receptor blocker doxazosin. J Hypertens 20, 463-470, doi: 10.1097/00004872-200203000-00022 (2002).
31. Morrow, D. et al. Cyclic strain inhibits Notch receptor signaling in vascular smooth muscle cells in vitro. Circ Res 96, 567-575, doi: 10.1161/01.RES.0000159182.98874.43 (2005).
32. Li, X. et al. Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 15, 1289-1297, doi: 10.1038/nm.2021 (2009).
33. Morrow, D. et al. Notch and vascular smooth muscle cell phenotype. Circ Res 103, 1370-1382, doi: 10.1161/CIRCRESAHA.108.187534 (2008).
34. Krawczyk, K. K. et al. Myocardin Family Members Drive Formation of Caveolae. PLoS One 10, e0133931, doi: 10.1371/journal.pone.0133931 (2015).
35. Kamath, B. M. et al. Vascular anomalies in Alagille syndrome: A significant cause of morbidity and mortality. Circulation 109, 1354-1358, doi: 10.1161/01.CIR.0000121361.01862.A4 (2004).
36. Oda, T. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16, 235-242, doi: 10.1038/ng0797-235 (1997).
37. Joutel, A. et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383, 707-710, doi: 10.1038/383707a0 (1996).
38. Hoffmann, T. J. et al. Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat Genet 49, 54-64, doi: 10.1038/ng.3715 (2016).
39. Logeat, F. et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci USA 95, 8108-8112, doi: 10.1073/pnas.95.14.8108 (1998).
40. Palao, T. et al. Gene Expression and MicroRNA Expression Analysis in Small Arteries of Spontaneously Hypertensive Rats. Evidence for ER Stress. PLoS One 10, e0137027, doi: 10.1371/journal.pone.0137027 (2015).
41. Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264, doi: 10.1093/biostatistics/4.2.249 (2003).
42. Veerla, S., Ringner, M. & Hoglund, M. Genome-wide transcription factor binding site/promoter databases for the analysis of gene sets and co-occurrence of transcription factor binding motifs. BMC Genomics 11, 145, doi: 10.1186/1471-2164-11-145 (2010).
43. Krawczyk, K. K. et al. Assessing the contribution of thrombospondin-4 induction and ATF6alpha activation to endoplasmic reticulum expansion and phenotypic modulation in bladder outlet obstruction. Sci Rep 6, 32449, doi: 10.1038/srep32449 (2016).
44. Turczynska, K. M., Sadegh, M. K., Hellstrand, P., Sward, K. & Albinsson, S. MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels. J Biol Chem 287, 19199-19206, doi: 10.1074/jbc.M112.341073 (2012).
45. Sward, K., Albinsson, S. & Rippe, C. Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice. PLoS One 9, e92428, doi: 10.1371/journal.pone.0092428 (2014).
46. Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580-585, doi: 10.1038/ng.2653 (2013).
47. Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11, R25, doi: 10.1186/gb-2010-11-3-r25 (2010).